PluroGel is a wound dressing gel made from concentrated surfactant technology, designed to keep wounds moist and help the body naturally clear away dead tissue. It comes in two versions: a prescription antimicrobial formula for serious wounds and an over-the-counter version for everyday cuts, burns, and scrapes. The product is manufactured by Medline Industries and has FDA clearance as a wound dressing.
How PluroGel Works
PluroGel uses a concentrated, cell-friendly surfactant, a type of compound that loosens and lifts debris from surfaces. In wound care, this means the gel helps separate dead or damaged tissue from the healthy wound bed without harming living cells. This process is called autolytic debridement: the gel maintains moisture so your body’s own enzymes can break down necrotic tissue naturally, rather than requiring manual removal.
Keeping a wound moist is one of the most well-established principles in wound healing. Dry wounds form hard scabs that can slow cell migration and delay closure. PluroGel creates a consistently moist environment that supports the body’s repair process while the surfactant component works to loosen wound debris and help manage biofilm, the sticky colonies of bacteria that can form on chronic wound surfaces and resist standard treatment.
What It’s Used For
The prescription version, PluroGel Antimicrobial Burn and Wound Dressing, covers a wide range of wound types. Its FDA-cleared indications include:
- Full and partial thickness wounds, meaning injuries that extend through some or all layers of the skin
- Pressure ulcers (bedsores)
- Diabetic foot ulcers and other leg ulcers
- First and second degree burns
- Surgical wounds, including donor sites where skin grafts were harvested
The over-the-counter version is simpler in scope. It’s indicated for minor cuts, minor burns, and minor lacerations. If you’ve picked up PluroGel at a pharmacy without a prescription, this is the version you have, and it’s meant for everyday wound care rather than complex or chronic wounds.
How to Apply It
PluroGel is applied directly to the wound bed as a gel layer, then typically covered with a secondary dressing to hold it in place and protect the area. Dressing changes generally happen every one to three days, depending on the wound type, how much fluid the wound produces, and your healthcare provider’s instructions. Wounds that produce a lot of drainage may need more frequent changes, while cleaner, drier wounds can go longer between applications.
The gel rinses away easily at each dressing change, which is a practical advantage. Many wound dressings can stick to the wound bed and cause pain or tissue damage during removal. Because PluroGel stays in a soft gel form and loosens debris rather than adhering to tissue, changing the dressing tends to be less painful than with traditional gauze or dry dressings.
Prescription vs. OTC Versions
The key difference between the two versions is the antimicrobial component. The prescription PluroGel Antimicrobial formula is classified by the FDA as a combination product, meaning it pairs the wound dressing function with an active agent that helps control bacteria in the wound. This makes it appropriate for wounds at higher risk of infection, such as deep pressure ulcers, diabetic foot wounds, or burn injuries where bacterial colonization is a serious concern.
The OTC version lacks the antimicrobial component and is a straightforward moist wound dressing for minor injuries. Both versions share the same basic surfactant technology and moisture-retention properties, but the prescription formula is designed for wounds that need more aggressive management under clinical supervision.
FDA Classification and Regulatory Status
PluroGel received FDA clearance through the 510(k) pathway, which means the manufacturer (Medline Industries, based in Northfield, Illinois) demonstrated that the product is substantially equivalent to an existing legally marketed device. It’s classified under the product code FRO, which covers drug-containing wound dressings. This is a device clearance, not a drug approval, though the antimicrobial version’s combination product status reflects that it does more than a simple bandage.
Being FDA-cleared means the product has met safety and performance standards, but it’s worth understanding that the 510(k) pathway does not require the same level of clinical trial data as full drug approval. The clearance is based on demonstrating equivalence to products already on the market rather than proving effectiveness through large-scale trials from scratch.
Where PluroGel Fits in Wound Care
PluroGel occupies a specific niche between basic wound dressings and more aggressive interventions. For chronic wounds like diabetic ulcers or pressure injuries, removing dead tissue is essential for healing, but the methods range from surgical debridement (physically cutting away dead tissue) to enzymatic ointments to autolytic approaches like PluroGel. The autolytic route is the gentlest option, relying on the body’s own processes rather than external chemicals or sharp instruments.
This makes PluroGel particularly useful for patients who can’t tolerate more aggressive debridement, for wounds that need consistent moisture management between clinical visits, or as a maintenance strategy after initial wound bed preparation. It’s not a replacement for surgical intervention when a wound has significant necrotic tissue, but for ongoing wound management, the combination of moisture retention, surfactant-based cleaning, and (in the Rx version) antimicrobial protection addresses several wound care needs in a single product.